Screener
Artiva Biotherapeutics, Inc. ARTV Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$25.01M-17.6% | -$23.52M-15.8% | -$20.77M-29.1% | -$21.53M-23.2% | -$21.25M-19.1% | ||
| $692K+8.0% | $666K+6.1% | $666K+8.5% | $662K+5.6% | $641K+6.3% | ||
| $1.87M+20.4% | $1.59M-22.4% | $1.59M-27.2% | $1.63M-14.5% | $1.55M+4.5% | ||
| -$20.36M+11.4% | -$20.95M-5.6% | -$14.73M-0.5% | -$19.2M-65.4% | -$22.98M-67.9% | ||
| $415K-60.7% | $242K-52.6% | $421K+558% | $600K+525% | $1.06M+127% | ||
| $17.59M-16.7% | $15.32M+53.6% | $16.04M+1,760% | $16.28M+112% | $21.12M+1,466% | ||
| $283.27M— | -$112K-147% | —— | —— | —— | ||
| $280.5M+14,611% | -$5.75M+40.3% | $0+100% | -$2.96M-114% | -$1.93M+86.1% | ||
| -$20.77M+13.6% | -$21.19M-4.1% | -$15.15M-2.9% | -$19.8M-69.1% | -$24.04M-69.9% |
FAQ
- How much cash does Artiva Biotherapeutics, Inc. generate?
- Artiva Biotherapeutics, Inc. (ARTV) generated -$75.2M in operating cash flow over the trailing twelve months.
- What is Artiva Biotherapeutics, Inc.'s free cash flow?
- After $1.7M of capital expenditures, Artiva Biotherapeutics, Inc.'s free cash flow was -$76.9M over the trailing twelve months, down 8.6% year over year.
- Where does Artiva Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.